Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.

MLA

Mohamed, Amira, et al. “Pasireotide and Octreotide Antiproliferative Effects and Sst2 Trafficking in Human Pancreatic Neuroendocrine Tumor Cultures.” Endocrine-Related Cancer, vol. 21, no. 5, Oct. 2014, pp. 691–704. EBSCOhost, https://doi.org/10.1530/ERC-14-0086.

APA

Mohamed, A., Blanchard, M.-P., Albertelli, M., Barbieri, F., Brue, T., Niccoli, P., Delpero, J.-R., Monges, G., Garcia, S., Ferone, D., Florio, T., Enjalbert, A., Moutardier, V., Schonbrunn, A., Gerard, C., Barlier, A., & Saveanu, A. (2014). Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures. Endocrine-Related Cancer, 21(5), 691–704. https://doi.org/10.1530/ERC-14-0086

Chicago

Mohamed, Amira, Marie-Pierre Blanchard, Manuela Albertelli, Federica Barbieri, Thierry Brue, Patricia Niccoli, Jean-Robert Delpero, et al. 2014. “Pasireotide and Octreotide Antiproliferative Effects and Sst2 Trafficking in Human Pancreatic Neuroendocrine Tumor Cultures.” Endocrine-Related Cancer 21 (5): 691–704. doi:10.1530/ERC-14-0086.